Dr Loretta Dorstyn

Senior Research Fellow

Centre for Cancer Biology

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.


Dr Loretta Dorstyn is a Senior Research Fellow and Project Leader at the Centre for Cancer Biology (CCB - UniSA and SA Pathology). Loretta has over 20 years experience in molecular and cellular biology and understanding of the fundamental process of programmed cell death (mostly apoptosis) during development and in disease. Loretta received her PhD from the University of Adelaide where she cloned and characterised two novel apoptosis enzymes (caspases) in the model organism and fruit fly, Drosophila melanogaster. She then spent 8 years studying the roles and mechanisms of caspases, including how they are activated and regulated during apoptosis. Over this time she was awarded a RAH Florey Fellowship that fostered her independent research where she initiated several apoptosis-related projects.
In 2012 she was awarded a South Australian Cancer Collaborative Senior Research Fellowship and transitioned to project leader at the CCB. Over this time, Loretta established several independent projects that focused on understanding how cell death mechanisms act to maintain cell homeostasis and genome integrity. Her projects led to numerous seminal findings detailing cell death mechanisms in tumour suppression, DNA damage repair, genomic stability, oxidative stress and healthy ageing. She has spent the last 10 years studying different mouse tumour models to better understand caspase regulation and roles in tumour suppression and has gained extensive expertise in tumour biology, as well as genomic, proteomic and bioinformatic analyses. Loretta's current work aims to understand how cells can evade checkpoint or “safety net” mechanisms during cell division and thereby acquire persistent DNA alterations and mutations. This phenomenon is known as genomic instability and is one of the key hallmarks ageing-related diseases such as cancer. Her current research focus is to understand how genomic instability increases with age and drives tissue damage, inflammation and age-related cancer including liver, gut and bone marrow cancers.

Tumour suppression by apoptotic Caspases

Caspases are the main enzymes that initiate and execute cell death by apoptosis. Our work has focussed on functional analysis of caspase-2, one of the first caspases discovered and has identified the apoptotic and non-apoptotic functions of this caspase. I was part of the team that described the function of caspase-2 in apoptosis induced by cytotoxic drugs that disrupt the cytoskeleton (Ho et al. 2008, Oncogene). This was followed by the first seminal demonstration that caspase-2 acts as a tumour suppressor in mice  (Ho et al., 2009, Proc Natl Acad Sci USA). These findings led to further studies using various different mouse tumour models to define the role of caspase-2 in tumour suppression. In particular, the mouse thymoma model (Atm knockout mice) was used to demonstrate genetic interaction between Atm and caspase-2 in tumour suppression and enhanced tumour development in a caspase-2 knockout background (Puccini et al., 2013, Proc Natl Acad Sci USA). Interestingly, I also demonstrated that loss of caspase-2 can in fact delay tumour onset in a MYCN transgenic neuroblastoma mouse model (Dorstyn et al., 2014, Cell Death Dis). These findings indicated that caspase-2 has very defined tissue specific and context specific roles in tumour suppression and we are currently investigating the mechanisms by which it mediates these opposing functions.

Regulation of cellular stress pathways

  • Caspase-2 function in genomic stability: My studies have demonstrated that loss of the caspase-2 gene leads to increased proliferation of primary fibroblasts, enhanced cell immortalisation and the accumulation of cells with DNA damage and aneuploidy (abnormal chromosome number) that drives genome instability (Dorstyn et al., 2012, Cell Death Differ). These studies also demonstrated that caspase-2 acts upstream of the tumour suppressor protein p53 in the DNA damage response pathway. Loss of caspase-2 significantly reduces p53 activation levels while stabilising c-Myc levels and our current work is aimed at understanding these roles.  In further studies published in two recent papers (Dawar et al., 2017, Oncogene; Dawar et al., 2016, Cell Death Dis) we report that caspase-2 is essential for the efficient removal of cells carrying mitotic aberrations, especially those with abnormal nuclei or aneuploidy. We discovered that cells that lack caspase-2 have abnormal cell division “checkpoints” that normally prevent damaged cells from surviving and becoming aneuploid. As a consequence, ageing mice that are deficient in caspase-2 accumulate aneuploid cells in their tissues (e.g. bone marrow, spleen, liver) with ageing. These findings indicate that caspase-2 plays a critical role in preventing the long-term survival and growth of cells that could otherwise become malignant, thus proving a mechanism for tumour suppression by this caspase. 
  • Caspase-2 regulation of oxidative stress and ageing: In a paper published in Oncogene (Shalini et al., 2015), we demonstrated that caspase-2 deficiency exacerbates cellular stress in mice following low dose challenge with the potent reactive oxygen species (ROS) generator, paraquat (PQ). This was shown to be due to increased inflammation and impaired response to oxidative stress, including failure to upregulate the antioxidant defence mechanism in animals lacking caspase-2. Interestingly, we found that Casp2-/- mice exhibited more severe lung and liver lesions with extensive karyomegaly, a feature commonly associated with ageing and genomic instability. Thus, our work indicates that caspase-2 is critical in regulating the oxidative stress response and in preventing cellular stress and pre-mature ageing. We also made the direct demonstration that the absence of caspase-2 function and activity, accelerates oxidative stress-induced chronic liver cancer (hepatocellular carcinoma) as well as age-related chronic liver inflammation and HCC (Shalini et al., 2016, Cell Death Differ; Dorstyn et al., 2025 under review).

By preventing genomic instability and regulating the oxidative stress response, caspase-2 acts as a key cell surveillance protein and as a consequence is important to prevent tissue dysfunction and pre-mature ageing in mice. We are currently interested in understanding the molecular basis of these mechanisms in healthy ageing, maintaining normal tissue function and role in age-related diseases, including cancer.

Date Position Institution name
2022 - ongoing Research Degree Coordinator University of South Australia
2012 - ongoing Senior Research Fellow and Project Leader University of South Australia
2012 - 2015 SACRC Senior Research Fellow South Australia Pathology
2009 - 2011 Research Officer South Australia Pathology
2005 - ongoing Affiliate Senior Lecturer University of Adelaide
2005 - 2008 Royal Adelaide Hospital Florey Fellow Royal Adelaide Hospital
2001 - 2004 Research Officer Institute of Medical and Veterinary Sciences

Date Type Title Institution Name Country Amount
2012 Fellowship South Australian Cancer Research Collaborative Senior Research Fellowship Cancer Council SA Australia -
2005 Fellowship Royal Adelaide Hospital Florey Research Fellowship Royal Adelaide Hospital Australia -

Date Institution name Country Title
1997 - 2001 University of Adelaide Australia PhD
1996 - 1996 University of Adelaide Australia BSc - Honours (First Class)
1993 - 1995 University of Adelaide Australia BSc

Year Citation
2026 Dorstyn, L., Lim, Y., Scanlan, J., McLennan, E., De Bellis, D., Katschner, M., . . . Kumar, S. (2026). Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice. SCIENCE ADVANCES, 12(1), 20 pages.
DOI
2024 Umargamwala, R., Manning, J., Dorstyn, L., Denton, D., & Kumar, S. (2024). Understanding Developmental Cell Death Using Drosophila as a Model System. Cells, 13(4), 347-1-347-16.
DOI Scopus3 WoS2 Europe PMC1
2022 Kumar, S., Dorstyn, L., & Lim, Y. (2022). The role of caspases as executioners of apoptosis. Biochemical Society Transactions, 50(1), 33-45.
DOI Scopus46 WoS42 Europe PMC40
2021 Lim, Y., De Bellis, D., Sandow, J. J., Capalbo, L., D'Avino, P. P., Murphy, J. M., . . . Kumar, S. (2021). Phosphorylation by Aurora B kinase regulates caspase-2 activity and function.. Cell Death and Differentiation, 28(1), 349-366.
DOI Scopus25 WoS24 Europe PMC24
2021 Lim, Y., Dorstyn, L., & Kumar, S. (2021). The p53-caspase-2 axis in the cell cycle and DNA damage response. Experimental and Molecular Medicine, 53(4), 517-527.
DOI Scopus44 WoS40 Europe PMC37
2020 Dorstyn, L., Tvorogov, D., Malek, S., & Robinson, N. (2020). The 9th Barossa Meeting: Cell Signalling in Cancer Medicine. Cell Death and Disease, 11(3), 3 pages.
DOI
2019 Dorstyn, L., Hackett-Jones, E., Nikolic, A., Norris, M. D., Lim, Y., Toubia, J., . . . Kumar, S. (2019). Transcriptome profiling of caspase-2 deficient EµMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling. Cell Death and Disease, 10(2), 56-1-56-16.
DOI Scopus7 WoS6 Europe PMC6
2018 Dorstyn, L., Akey, C. W., & Kumar, S. (2018). New insights into apoptosome structure and function. Cell Death and Differentiation, 25(7), 1194-1208.
DOI Scopus182 WoS171 Europe PMC154
2018 Lim, Y., De Bellis, D., Dorstyn, L., & Kumar, S. (2018). p53 accumulation following cytokinesis failure in the absence of caspase-2. Cell Death and Differentiation, 25(11), 2050-2052.
DOI Scopus11 WoS10 Europe PMC10
2017 Wilson, C., Nikolic, A., Kentish, S., Keller, M., Hatzinikolas, G., Dorstyn, L., . . . Kumar, S. (2017). Caspase-2 deficiency enhances whole-body carbohydrate utilisation and prevents high-fat diet-induced obesity. Cell Death and Disease, 8(10), e3136-1-e3136-12.
DOI Scopus14 WoS14 Europe PMC13
2017 Dawar, S., Lim, Y., Puccini, J., White, M., Thomas, P., Bouchier-Hayes, L., . . . Kumar, S. (2017). Caspase-2-mediated cell death is required for deleting aneuploid cells. Oncogene, 36(19), 2704-2714.
DOI Scopus55 WoS52 Europe PMC50
2016 Wilson, C. H., Dorstyn, L., & Kumar, S. (2016). Fat, sex and caspase-2. Cell Death and Disease, 7(e2125), 1-2.
DOI Scopus2 WoS2 Europe PMC1
2016 Shalini, S., Nikolic, A., Wilson, C., Puccini, J., Sladojevic, N., Finnie, J., . . . Kumar, S. (2016). Caspase-2 deficiency accelerates chemically induced liver cancer in mice. Cell Death and Differentiation, 23(10), 1727-1736.
DOI Scopus35 WoS32 Europe PMC28
2016 Wilson, C., Nikolic, A., Kentish, S., Shalini, S., Hatzinikolas, G., Page, A., . . . Kumar, S. (2016). Sex-specific alterations in glucose homeostasis and metabolic parameters during ageing of caspase-2-deficient mice. Cell Death Discovery, 2(16009), 16009-1-16009-10.
DOI Scopus15 WoS15 Europe PMC12
2016 Dawar, S., Shahrin, N., Sladojevic, N., D'Andrea, R., Dorstyn, L., Hiwase, D., & Kumar, S. (2016). Impaired haematopoietic stem cell differentiation and enhanced skewing towards myeloid progenitors in aged caspase-2-deficient mice. Cell Death and Disease, 7(12), e2509-1-e2509-9.
DOI Scopus26 WoS27 Europe PMC27
2015 Wilson, C., Shalini, S., Filipovska, A., Richman, T., Davies, S., Martin, S., . . . Kumar, S. (2015). Age-related proteostasis and metabolic alterations in Caspase-2-deficient mice. Cell Death & Disease, 6(1), e1597-1-e1597-12.
DOI Scopus38 WoS37 Europe PMC34
2015 Shalini, S., Dorstyn, L., Dawar, S., & Kumar, S. (2015). Old, new and emerging functions of caspases. Cell Death and Differentiation, 22(4), 526-539.
DOI Scopus1082 WoS1021 Europe PMC865
2015 Peintner, L., Dorstyn, L., Kumar, S., Aneichyk, T., Villunger, A., & Manzl, C. (2015). The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd. Cell Death and Differentiation, 22(11), 1803-1811.
DOI Scopus23 WoS21 Europe PMC17
2014 Dorstyn, L., & Kumar, S. (2014). Caspase-2 protocols. Methods in Molecular Biology, 1133, 71-87.
DOI
2014 Dorstyn, L., Puccini, J., Nikolic, A., Shalini, S., Wilson, C., Norris, M., . . . Kumar, S. (2014). An unexpected role for caspase-2 in neuroblastoma. Cell Death and Disease, 5(8), e1383-1-e1383-9.
DOI Scopus21 WoS20 Europe PMC16
2014 Sandow, J., Dorstyn, L., O'Reilly, L., Tailler, M., Kumar, S., Strasser, A., & Ekert, P. (2014). ER stress does not cause upregulation and activation of caspase-2 to initiate apoptosis. Cell Death and Differentiation, 21(3), 475-480.
DOI Scopus51 WoS47 Europe PMC47
2014 Shalini, S., Puccini, J., Wilson, C., Finnie, J., Dorstyn, L., & Kumar, S. (2014). Caspase-2 protects against oxidative stress in vivo. Oncogene, 34(38), 4995-5002.
DOI Scopus30 WoS26 Europe PMC23
2013 Puccini, J., Dorstyn, L., & Kumar, S. (2013). Genetic background and tumour susceptibility in mouse models. Cell Death and Differentiation, 20(7), 964.
DOI Scopus13 WoS13 Europe PMC13
2013 Puccini, J., Shalini, S., Voss, A., Gatei, M., Wilson, C., Hiwase, D., . . . Kumar, S. (2013). Loss of caspase-2 augments lymphomagenesis and enhances genomic instability in Atm-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 110(49), 19920-19925.
DOI Scopus62 WoS57 Europe PMC56
2013 Puccini, J., Dorstyn, L., & Kumar, S. (2013). Caspase-2 as a tumour suppressor. Cell Death and Differentiation, 20(9), 1133-1139.
DOI Scopus87 WoS84 Europe PMC69
2012 Shalini, S., Dorstyn, L., Wilson, C., Puccini, J., Ho, L., & Kumar, S. (2012). Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice. Cell Death and Differentiation, 19(8), 1370-1380.
DOI Scopus78 WoS69 Europe PMC63
2012 Dorstyn, L., Puccini, J., Wilson, C., Shalini, S., Nicola, M., Moore, S., & Kumar, S. (2012). Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability. Cell Death and Differentiation, 19(8), 1288-1298.
DOI Scopus90 WoS89 Europe PMC82
2012 Dorstyn, L., Puccini, J., Wilson, C. H., Shalini, S., Nicola, M., Moore, S., & Kumar, S. (2012). Erratum: Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability (Cell Death and Differentiation (2012) 19 (1288-1298) DOI: 10.1038/cdd.2012.36). Cell Death and Differentiation, 19(8), 1411.
DOI Scopus2
2011 Wati, S., Rawlinson, S., Ivanov, R., Dorstyn, L., Beard, M., Jans, D., . . . Carr, J. (2011). Tumour necrosis factor alpha (TNF-α) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-α to activate nuclear factor κB and reduced sphingosine kinase-1 activity. Journal of General Virology, 92(4), 807-818.
DOI Scopus46 WoS46 Europe PMC44
2011 Yuan, S., Yu, X., Topf, M., Dorstyn, L., Kumar, S., Ludtke, S., & Akey, C. (2011). Structure of the Drosophila apoptosome at 6.9 Å resolution. Structure, 19(1), 128-140.
DOI Scopus71 WoS65 Europe PMC58
2011 Foot, N., Leong, Y., Dorstyn, L., Dalton, H., Ho, K., Zhao, L., . . . Kumar, S. (2011). Ndfip1-deficient mice have impaired DMT1 regulation and iron homeostasis. Blood, 117(2), 638-646.
DOI Scopus41 WoS39 Europe PMC40
2009 Kumar, S., & Dorstyn, L. (2009). Analysing caspase activation and caspase activity in apoptotic cells. Methods in Molecular Biology, 559, 3-17.
DOI Scopus17 Europe PMC11
2009 Howitt, J., Putz, U., Lackovic, J., Doan, A., Dorstyn, L., Cheng, H., . . . Tan, S. (2009). Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons. Proceedings of the National Academy of Sciences of the United States of America, 106(36), 15489-15494.
DOI Scopus103 WoS101 Europe PMC95
2009 Ho, L., Taylor, R., Dorstyn, L., Cakouros, D., Bouillet, P., & Kumar, S. (2009). A tumor suppressor function for caspase-2. Proceedings of the National Academy of Sciences of the United States of America, 106(13), 5336-5341.
DOI Scopus152 WoS142 Europe PMC137
2009 Dorstyn, L., & Kumar, S. (2009). Putative functions of caspase-2. F1000 biology reports, 1(96), 1-5.
DOI Europe PMC2
2008 Ho, L., Read, S., Dorstyn, L., Lambrusco, L., & Kumar, S. (2008). Capase-2 is required for cell death induced by cytoskeletal disruption. Oncogene, 27(24), 3393-3404.
DOI Scopus111 WoS104 Europe PMC102
2008 Foot, N., Dalton, H., Shearwin-Whyatt, L., Dorstyn, L., Tan, S., Yang, B., & Kumar, S. (2008). Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2. Blood, 112(10), 4268-4275.
DOI Scopus125 WoS119 Europe PMC116
2008 Dorstyn, L., & Kumar, S. (2008). A biochemical analysis of the activation of the Drosophila caspase DRONC. Cell Death and Differentiation, 15(3), 461-470.
DOI Scopus53 WoS48 Europe PMC43
2007 Doumanis, J., Dorstyn, L., & Kumar, S. (2007). Molecular determinants of the subcellular localization of the Drosophila Bcl-2 homologues DEBCL and BUFFY. Cell Death and Differentiation, 14(5), 907-915.
DOI Scopus27 WoS27 Europe PMC23
2006 Dorstyn, L., & Kumar, S. (2006). A cytochrome c-free fly apoptosome. Cell Death and Differentiation, 13(7), 1049-1051.
DOI Scopus26 WoS24 Europe PMC22
2004 Dorstyn, L., Mills, K., Lazebnik, Y., & Kumar, S. (2004). The two cytochrome c species, DC3 and DC4, are not required for caspase activation and apoptosis in Drosophila cells. Journal of Cell Biology, 167(3), 405-410.
DOI Scopus107 WoS105 Europe PMC98
2002 Dorstyn, L., Read, S., Cakouros, D., Huh, J., Hay, B., & Kumar, S. (2002). The role of cytochrome c in caspase activation in Drosophila melanogaster cells. Journal of Cell Biology, 156(6), 1089-1098.
DOI Scopus172 WoS166 Europe PMC148
2001 Harvey, N., Daish, T., Mills, K., Dorstyn, L., Quinn, L., Read, S., . . . Kumar, S. (2001). Characterization of the Drosophila caspase, DAMM. Journal of Biological Chemistry, 276(27), 25342-25350.
DOI Scopus76 WoS67 Europe PMC64
2000 Quinn, L., Dorstyn, L., Mills, K., Colussi, P., Chen, P., Coombe, M., . . . Richardson, H. (2000). An essential role for the caspase dronc in developmentally programmed cell death in Drosophila. Journal of Biological Chemistry, 275(51), 40416-40424.
DOI Scopus136 WoS131 Europe PMC120
2000 Dorstyn, L., Read, S. H., Quinn, L. M., Richardson, H., & Kumar, S. (2000). Erratum: DECAY, a novel Drosophila caspase related to mammalian caspase- 3 and caspase-7 (Journal of Biological Chemistry (1999) 274 (30778-30783)). Journal of Biological Chemistry, 275(20), 15600.
DOI
2000 Dorstyn, L., Read, S. H., Quinn, L. M., Richardson, H., & Kumar, S. (2000). DECAY, a novel <i>Drosophila</i> caspase related to mammalian caspase-3 and caspase-7 (vol 274, pg 30778, 1999). JOURNAL OF BIOLOGICAL CHEMISTRY, 275(20), 15600.
WoS1
1999 Dorstyn, L., Read, S., Quinn, L., Richardson, H., & Kumar, S. (1999). DECAY, a novel Drosophila caspase related to mammalian Caspase-3 and Caspase-7. Journal of Biological Chemistry, 274(43), 30778-30783.
DOI Scopus113 WoS107 Europe PMC94
1999 Dorstyn, L., Colussi, P., Quinn, L., Richardson, H., & Kumar, S. (1999). DRONC, an ecdysone-inducible Drosophila caspase. Proceedings of the National Academy of Sciences of the United States of America, 96(36251), 4307-4312.
DOI Scopus253 WoS248 Europe PMC212
1997 Dorstyn, L., & Kumar, S. (1997). Differential inhibitory effects of CrmA, P35, IAP and three mammalian IAP homologues on apoptosis in NIH3T3 cells following various death stimuli. Cell Death and Differentiation, 4(7), 570-579.
DOI Scopus26 WoS26 Europe PMC22
1997 Kumar, S., Kinoshita, M., Dorstyn, L., & Noda, M. (1997). Origin, expression and possible functions of the two alternatively spliced forms of the mouse Nedd2 mRNA. Cell Death and Differentiation, 4(5), 378-387.
DOI Scopus28 WoS28

Year Citation
2014 Dorstyn, L., & Kumar, S. (2014). Caspase-2 protocols. In P. Bozhkov, & G. Salvasen (Eds.), Caspases, paracaspases and metacaspases: methods and protocols (Vol. 1133, pp. 71-87). Humana Press.
DOI Scopus6 Europe PMC7
2013 Dorstyn, L., & Kumar, S. (2013). Insect Caspases. In N. Rawlings, & G. Salvesen (Eds.), Handbook of Proteolytic Enzymes, Volume 2 (Vol. 2, 3 ed., pp. 2286-2295). United Kingdom: Elsevier.
DOI Scopus1
2005 Dorstyn, L., & Kumar, S. (2005). Programmed cell death in drosophila melanogaster. In When Cells Die II A Comprehensive Evaluation of Apoptosis and Programmed Cell Death (pp. 79-97).
Scopus1
1998 Dorstyn, L. E., Kumar, S., & Kinoshita, M. (1998). Caspases in Cell Death. In S. Kumar (Ed.), Apoptosis: Mechanisms and Role in Disease (Vol. 24, pp. 1-24). Springer New York.
DOI Scopus12 Europe PMC4

Year Citation
2022 Kumar, S., Lim, Y., & Dorstyn, L. (2022). Tumor and aneuploidy suppression by caspase-2. In CANCER SCIENCE Vol. 113 (pp. 1 page). WILEY.
  • Deciphering the mechanisms of caspase-2-mediated suppression of aneuploidy and tumourigenesis, NHMRC - Project Grant, 01/01/2019 - 31/12/2021

  • Using mouse models to decipher the function of caspase-2 in limiting aneuploidy tolerance and cancer, NHMRC - Project Grant, 01/01/2018 - 30/06/2021

  • Deciphering the function of capcase-2 in DNA damage response and tumour suppression, NHMRC - Project Grant, 01/01/2014 - 31/12/2017

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Principal Supervisor Exploring the mechanisms of age-related polyploidy in inflammation and liver cancer Doctor of Philosophy Doctorate Full Time Mr Manish Kumar Vuriti

Date Role Research Topic Program Degree Type Student Load Student Name
2012 - 2016 Co-Supervisor Characterisation of Pathophysiological Function of NEDD4-2 in Kidney Doctor of Philosophy Doctorate Full Time Mr Pranay Goel
2010 - 2014 Co-Supervisor Characterisation of Caspase-2 Function in the DNA Damage Response and Tumour Suppression Doctor of Philosophy Doctorate Full Time Mr Joey Puccini

Date Role Committee Institution Country
2019 - 2023 Member Conference Organising Committee Centre for Cancer Biology Australia
2014 - ongoing Member Centre for Cancer Biology Faculty Centre for Cancer Biology Australia
2011 - ongoing Member NHMRC GRP National Health and Medical Research Council Australia
2010 - ongoing Member F1000 Associate Member Faculty of 1000 (United States) United States

Date Role Membership Country
2020 - ongoing Member Australasian Cell Death Society -
2012 - ongoing Member Australia and New Zealand Society for Cell and Developmental Biology -
2012 - ongoing Member Australian Society for Medical Research -
2002 - ongoing Member The Australian Society for Biochemistry and Molecular Biology -

Date Title Engagement Type Institution Country
2027 - 2017 Researchers find link between common enzyme and cancer prevention Scientific Community Engagement Medical Xpress (online article) Australia
2014 - 2017 Researcher Showcase Discussion Panel (Public Event) Public Community Engagement Cancer Council SA Australia
2009 - ongoing Caspase-2 Scientific Community Engagement Springer Nature (United Kingdom) United Kingdom

Date Role Editorial Board Name Institution Country
2024 - ongoing Member Frontiers in Cell Death -Community reviewer for Inflammation and Cytotoxicity Frontiers in Cell Death United States

Date Title Type Institution Country
2024 - ongoing Grant Review Grant Assessment Swiss National Science Foundation Switzerland
2019 - ongoing Grant Review Grant Assessment Health Research Council of New Zealand New Zealand
2018 - ongoing Grant Review Grant Assessment National Science Foundation United States
2011 - ongoing Grant Review Grant Assessment National Health and Medical Research Council Australia

Connect With Me

External Profiles

Other Links